SIGNATURES for Vical (VICL)

Vical (VICL)

VICL » Topics » SIGNATURES

VICL » Topics » SIGNATURES

"SIGNATURES" elsewhere:

EXCERPTS ON THIS PAGE:

RELATED TOPICS for VICL:

"SIGNATURES" elsewhere:

Send us Feedback

Vical (VICL)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

This excerpt taken from the VICL 8-K filed Dec 10, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

This excerpt taken from the VICL 8-K filed Nov 4, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vical Incorporated
Date: November 4, 2009	By:	/s/ JILL M. BROADFOOT Jill M. Broadfoot Senior Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Aug 6, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vical Incorporated
Date: August 6, 2009	By:	/s/ JILL M. BROADFOOT Jill M. Broadfoot Senior Vice President, Chief Financial Officer and Secretary

INDEX TO EXHIBITS

Exhibit No.		Description

99.1		Press release issued by Vical Incorporated on August 6, 2009.

This excerpt taken from the VICL 8-K filed Jul 28, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Dated: July 28, 2009	By:	/s/ Jill M. Broadfoot
		Jill M. Broadfoot
		Senior Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed May 26, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Dated: May 22, 2009	By:	/s/ Vijay B. Samant
		Vijay B. Samant President and Chief Executive Officer

This excerpt taken from the VICL 8-K filed May 22, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Dated: May 22, 2009	By:	/s/ Jill M. Broadfoot
		Jill M. Broadfoot
		Senior Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed May 7, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vical Incorporated
Dated: May 7, 2009	By:	/s/ JILL M. BROADFOOT Jill M. Broadfoot Senior Vice President, Chief Financial Officer and Secretary

INDEX TO EXHIBITS

Exhibit No.		Description

99.1		Press release issued by Vical Incorporated on May 7, 2009.

These excerpts taken from the VICL 10-K filed Mar 3, 2009.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 3, 2009


VICAL INCORPORATED
By:		/s/ VIJAY B. SAMANT
		Vijay B. Samant President and Chief Executive Officer

SIGNATURES

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

Date: March 3, 2009

STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">


VICAL INCORPORATED
By:		/s/ VIJAY B. SAMANT STYLE="font-size:2px;margin-top:0px;margin-bottom:1px" align="left">
		Vijay B. Samant FACE="Times New Roman" SIZE="1">President and Chief Executive Officer

EX-10.55
2
dex1055.htm
LICENSE AGREEMENT

License Agreement

These excerpts taken from the VICL 10-K filed Mar 3, 2009.

SIGNATURES

Date: March 3, 2009


VICAL INCORPORATED

By:		/s/ VIJAY B. SAMANT
		Vijay B. Samant
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



/S/ VIJAY B. SAMANT Vijay B. Samant	President, Chief Executive Officer and Director (Principal Executive Officer)	March 3, 2009

/S/ JILL M. BROADFOOT Jill M. Broadfoot	Senior Vice President, Chief Financial Officer, and Secretary (Principal Financial and Accounting Officer)	March 3, 2009

/S/ R. GORDON DOUGLAS, M.D. R. Gordon Douglas, M.D.	Chairman of the Board of Directors	March 3, 2009

/S/ ROBERT H. CAMPBELL Robert H. Campbell	Director	March 3, 2009

/S/ GARY A. LYONS Gary A. Lyons	Director	March 3, 2009

/S/ ROBERT C. MERTON, PH.D. Robert C. Merton, Ph.D.	Director	March 3, 2009

SIGNATURES

Date: March 3, 2009

STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">


VICAL INCORPORATED

By:		/s/ VIJAY B. SAMANT
		Vijay B. Samant
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



/S/ VIJAY B. SAMANT Vijay B. Samant	President, Chief Executive Officer and Director (Principal Executive Officer)	March 3, 2009

/S/ JILL M. BROADFOOT Jill M. Broadfoot	Senior Vice President, Chief Financial Officer, and Secretary (Principal Financial and Accounting Officer)	March 3, 2009

/S/ R. GORDON DOUGLAS, M.D. R. Gordon Douglas, M.D.	Chairman of the Board of Directors	March 3, 2009

/S/ ROBERT H. CAMPBELL Robert H. Campbell	Director	March 3, 2009

/S/ GARY A. LYONS Gary A. Lyons	Director	March 3, 2009

/S/ ROBERT C. MERTON, PH.D. Robert C. Merton, Ph.D.	Director	March 3, 2009

EX-10.58
2
dex1058.htm
FORM OF DELAYED ISSUANCE STOCK PURCHASE ELECTION AGREEMENT

Form of Delayed Issuance Stock Purchase Election Agreement

This excerpt taken from the VICL 8-K filed Feb 17, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vical Incorporated
Dated: February 17, 2009	By:	/s/ JILL M. BROADFOOT Jill M. Broadfoot Senior Vice President, Chief Financial Officer and Secretary

INDEX TO EXHIBITS

Exhibit No.		Description

99.1		Press release issued by Vical Incorporated on February 17, 2009.

This excerpt taken from the VICL 8-K filed Jan 15, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: January 15, 2009	By:	/s/ JILL M. CHURCH
		Jill M. Church
		Senior Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Jun 12, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: June 12, 2008	By:	/s/ JILL M. CHURCH
		Jill M. Church
		Vice President, Chief Financial Officer
		and Secretary

These excerpts taken from the VICL 10-K filed Mar 3, 2008.

SIGNATURES

Date: February 29, 2008


VICAL INCORPORATED

By:		/s/ VIJAY B. SAMANT
		Vijay B. Samant President and Chief Executive Officer



/S/ VIJAY B. SAMANT Vijay B. Samant	President, Chief Executive Officer and Director (Principal Executive Officer)	February 29, 2008

/S/ JILL M. CHURCH Jill M. Church	Vice President, Chief Financial Officer, and Secretary) (Principal Financial and Accounting Officer)	February 29, 2008

/S/ R. GORDON DOUGLAS, M.D. R. Gordon Douglas, M.D.	Chairman of the Board of Directors	February 29, 2008

/S/ ROBERT H. CAMPBELL Robert H. Campbell	Director	February 29, 2008

/S/ GARY A. LYONS Gary A. Lyons	Director	February 29, 2008

/S/ ROBERT C. MERTON, PH.D. Robert C. Merton, Ph.D.	Director	February 29, 2008

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIZE="2">Date: February 29, 2008


VICAL INCORPORATED

By:		/s/ VIJAY B. SAMANT
		Vijay B. Samant FACE="Times New Roman" SIZE="1">President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



/S/ VIJAY B. SAMANT Vijay B. Samant	President, Chief Executive Officer and Director (Principal Executive Officer)	February 29, 2008

/S/ JILL M. CHURCH Jill M. Church	Vice President, Chief Financial Officer, and Secretary) (Principal Financial and Accounting Officer)	February 29, 2008

/S/ R. GORDON DOUGLAS, M.D. R. Gordon Douglas, M.D.	Chairman of the Board of Directors	February 29, 2008

/S/ ROBERT H. CAMPBELL Robert H. Campbell	Director	February 29, 2008

/S/ GARY A. LYONS Gary A. Lyons	Director	February 29, 2008

/S/ ROBERT C. MERTON, PH.D. Robert C. Merton, Ph.D.	Director	February 29, 2008

EX-23.1
2
dex231.htm
CONSENT OF ERNST & YOUNG LLP

Consent of Ernst & Young LLP

This excerpt taken from the VICL 8-K filed Apr 18, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: April 18, 2007	By:	/s/ JILL M. CHURCH
		Jill M. Church
		Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 10-K filed Feb 23, 2007.

SIGNATURES

Date: February 22, 2007


VICAL INCORPORATED

By:		/s/ VIJAY B. SAMANT
		Vijay B. Samant
		President and Chief Executive Officer



/s/ VIJAY B. SAMANT Vijay B. Samant	President, Chief Executive Officer and Director (Principal Executive Officer)	February 22, 2007

/s/ JILL M. CHURCH Jill M. Church	Vice President, Chief Financial Officer, and Secretary (Principal Financial and Accounting Officer)	February 22, 2007

/s/ R. GORDON DOUGLAS, M.D. R. Gordon Douglas, M.D.	Chairman of the Board of Directors	February 22, 2007

/s/ ROBERT H. CAMPBELL Robert H. Campbell	Director	February 22, 2007

/s/ GARY A. LYONS Gary A. Lyons	Director	February 22, 2007

/s/ ROBERT C. MERTON, PH.D. Robert C. Merton, Ph.D.	Director	February 22, 2007

This excerpt taken from the VICL 8-K filed Feb 20, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICAL INCORPORATED


Date: February 20, 2007	By:	/s/ JILL M. CHURCH

		Jill M. Church
		Vice President, Chief Financial Officer
		and Secretary

This excerpt taken from the VICL 8-K filed Jan 8, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: January 8, 2007	By:	/s/ JILL M. CHURCH
		Jill M. Church
		Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Nov 2, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICAL INCORPORATED


Date: November 2, 2006	By:	/s/ JILL M. CHURCH

		Jill M. Church
		Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Oct 19, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: October 19, 2006	By:	/s/ JILL M. CHURCH
		Jill M. Church Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Oct 17, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: October 17, 2006	By:	/s/ JILL M. CHURCH
		Jill M. Church Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Aug 25, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: August 25, 2006	By:	/s/ JILL M. CHURCH
		Jill M. Church Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Aug 10, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VICAL INCORPORATED

Date: August 10, 2006	By:	/s/ JILL M. CHURCH
		Jill M. Church Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Aug 1, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICAL INCORPORATED


Date: August 1, 2006	By:	/s/ JILL M. CHURCH

		Jill M. Church
		Vice President, Chief Financial Officer and Secretary

This excerpt taken from the VICL 8-K filed Jun 13, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		VICAL INCORPORATED

Date:	June 13, 2006	By:	/s/ JILL M. CHURCH
			Jill M. Church
			Vice President, Chief Financial Officer and Secretary

INDEX TO EXHIBITS


Exhibit No.		Item

16.1		Letter from Deloitte & Touche LLP to the Securities and Exchange Commission dated June 12, 2006

This excerpt taken from the VICL 8-K filed Jun 8, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		VICAL INCORPORATED

Date:	June 7, 2006	By:	/s/ JILL M. CHURCH
			Jill M. Church
			Vice President, Chief Financial Officer and Secretary

INDEX TO EXHIBITS


Exhibit No.		Item

16.1		Letter from Deloitte & Touche LLP to the Securities and Exchange Commission dated June 6, 2006

ACADIA Pharmaceuticals (ACAD)
Affymax (AFFY)
AGENUS INC (AGEN)
Amarin (AMRN)
ARIAD Pharmaceuticals (ARIA)
BioCryst Pharmaceuticals (BCRX)
Biopure (BPUR)
Clinical Data (CLDA)
Corcept Therapeutics (CORT)
Curis (CRIS)
Cytokinetics (CYTK)
EPIX Pharmaceuticals (EPIX)
EXACT Sciences (EXAS)
GENETIC TECHNOLOGIES (GENE)
GenVec (GNVC)
GPC Biotech AG (GPCB)
GTC Biotherapeutics (GTCB)
IGI (IG)
ImmunoGen (IMGN)
IMMTECH PHARMACEUTICALS, INC. (IMM)
Inhibitex (INHX)
Iomai (IOMI)
InterMune (ITMN)
Metabasis Therapeutics (MBRX)
MEDICURE (MCU)
Memory Pharmaceuticals (MEMY)
Molecular Insight Pharmaceuticals (MIPI)
Micromet (MITI)
Matritech (MZT)
Biota Pharmaceuticals, Inc. (NABI)
Neose Technologies (NTEC)
Neurobiological Technologies (NTII)
Osiris Therapeutics (OSIR)
Pharmacopeia Drug Discovery (PCOP)
Progenics Pharmaceuticals (PGNX)
Polydex Pharmaceuticals (POLXF)
Peregrine Pharmaceuticals (PPHM)
QLT (QLTI)
Sangamo BioSciences (SGMO)
Sunesis Pharmaceuticals (SNSS)
Savient Pharmaceuticals (SVNT)
AmpliPhi Biosciences Corp (TGEN)
Theravance (THRX)
Trubion Pharmaceuticals (TRBN)
SYNAGEVA BIOPHARMA CORP (TRMS)
Vanda Pharmaceuticals (VNDA)
XenoPort (XNPT)
XOMA (XOMA)
CORD BLOOD AMERICA (CBAI)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

VICAL INCORPORATED

Dated: December 10, 2009

/s/ JILL M. BROADFOOT

Jill M. Broadfoot

Senior Vice President, Chief Financial Officer and Secretary